Award

Delivery Order #SPE2DR26F4G5P

Pharmaceutical Delivery Order for Guanfacine HCL Tablets to AmerisourceBergen

Buyer

Defense Logistics Agency

Award Amount

$225.48

Ceiling

$225.48

Awarded

February 13, 2026

Period of Performance

Feb 13, 2026 – Feb 17, 2026

Identifier

SPE2DR26F4G5P

NAICS

424210

This award is a delivery order contract under the existing indefinite delivery vehicle (IDV) held by AmerisourceBergen Drug Corp, a leading pharmaceutical sourcing and distribution company. The contract entails the procurement of Guanfacine HCL ER 1 mg tablets, a critical medication, reinforcing the company's role in supplying essential pharmaceuticals to healthcare entities. The significance of this order lies in its contribution to maintaining uninterrupted access to vital medications within the public health sector. The scope covers the delivery of specified medication units to a designated location in Conshohocken, Pennsylvania, under a short-term schedule lasting a few days in early 2026. This order supports the overarching IDV that facilitates pharmaceutical distribution services, ensuring reliable logistics and supply chain operations. The contract was awarded through established channels under the parent IDV agreement, reflecting a streamlined procurement process rather than competitive bidding for this specific delivery. Overall, this delivery order exemplifies continuous support for public healthcare needs by effectively managing pharmaceutical supplies within a multi-year framework.

Description

4570837221!GUANFACINE HCL ER 1 MG TABLET 100S

View original record